17hon MSN
SS Innovations International (OTCPK:SSII) has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine, the company said on Friday. In addition to ...
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United ...
“Making these chemicals immediately illegal until obtaining FDA approval may cause disruptions in the food supply. Ensuring that existing GRAS chemicals are safe to remain in our foods should be ...
The FDA last week approved (PDF) Neurotech’s cell therapy implant revakinagene taroretcel to treat the vision-robbing neurodegenerative disease macular telangiectasia (MacTel) type 2.
“That kind of casual neglect totally would be unacceptable in Europe,” Millstone said. ‘Several Decades Behind Europeans’ When the FDA formally approves substances for use in food, it can let decades ...
The approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) as the first and only FDA-approved treatment for macular telangiectasia type 2 (MacTel) marks a significant milestone ...
The agency updates and modifies the alerts as needed. Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Click here to go to the FDA page with links to ...
“So that we don’t learn five years after Vioxx was approved that 38,000 Americans died from it,” he said. Open questions: But the Johns Hopkins surgeon also said the FDA could potentially ...
When the FDA formally approves substances for use in food, it can let decades pass without reassessing them — even when subsequent research raises doubts about their safety. In the European ...
The products are expected to be available in June 2025. The US Food and Drug Administration (FDA) has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results